Launch Date: 11/30/2021
Expiration Date: 11/30/2022
Target Audience: This activity is designed for nurse practitioners (NPs), physician assistants (PAs), nurses and allied health professionals.
The goal of this program is to educate health care providers on the latest advances in interdisciplinary management of IBD.
Upon completion of this activity, participants should be able to:
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 0.75 contact hours may be earned for successful completion of this activity.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 11/30/2021 to 11/30/2022. AAPA reference number: CME-203822.
Disclosure of Conflicts of Interest:
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All staff at the Annenberg Center for Health Sciences at Eisenhower and the Gastroenterology & Hepatology Advanced Practice Providers here have no relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
This activity is supported by educational grants from AbbVie, Bristol-Myers Squibb, Ferring Pharmaceuticals, Inc., Janssen Biotech, Inc. and Takeda Pharmaceuticals U.S.A., Inc.